Skip to main content
Home / Current Medicinal Chemistry, Volume 12, Number 12
Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

More about this publication?
Volume 12, Number 12, 2005

Book review

Editorial [Hot Topic: Focus on Cannabinoids and Endocannabinoids (Guest Editor: Didier M. Lambert)]
pp. 1359-1359(1)
Author: Lambert, Didier M.

Favourites:
ADD

Review article

Current Knowledge on the Antagonists and Inverse Agonists of Cannabinoid Receptors
pp. 1361-1394(34)
Authors: Muccioli, G. G.; Lambert, D. M.

Favourites:
ADD

Recent Developments in the Medicinal Chemistry of Cannabimimetic Indoles, Pyrroles and Indenes
pp. 1395-1411(17)
Authors: Huffman, J. W.; Padgett, L. W.

Favourites:
ADD

Endocannabinoid-Related Enzymes as Drug Targets with Special Reference to N-Acylphosphatidylethanolamine-Hydrolyzing Phospholipase D
pp. 1413-1422(10)
Authors: Ueda, Natsuo; Okamoto, Yasuo; Tsuboi, Kazuhito

Favourites:
ADD

New Medium Oxacyclic O,N-Acetals and Related Open Analogues: Biological Activities
pp. 1423-1438(16)
Authors: Campos, Joaquin; Saniger, Estrella; Marchal, Juan A.; Aiello, Stefania; Suarez, Ines; Boulaiz, Houria; Aranega, Antonia; Gallo, Miguel A.; Espinosa, Antonio

Favourites:
ADD

Congestive Heart Failure: Pharmacological Agents and the Potential of BType Natriuretic Peptide
pp. 1439-1447(9)
Authors: James, Kenneth D.; Cataliotti, Alessandro; Schirger, John A.; Plonka, Shannon; Burnett Jr, John C.

Favourites:
ADD

Dual Antagonists of Integrins
pp. 1449-1466(18)
Authors: Nadrah, K.; Dolenc, M. S.

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content